The Latest Breaking News from Evolent Health

The Dow Jones Industrial Average dived as much as 394 points Wednesday on a hot inflation report — the consumer price index.

The Dow Jones Industrial Average fell Tuesday, as the 10-year Treasury yield and U.S. oil prices tumbled on recession fears.

Health care stock Evolent Health develops software to help care providers and payers control costs and deliver high value.

Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter:

Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24 hours, at $27.84 per share.

Upgrades

In an SEC filing, Cook County named Evolent Health Inc (NYSE:EVH) the sole third-party administrator for CountyCare Health Plan from fiscal 2023 through fiscal 2025. Piper Sandler analyst Jessica Tassan notes that the award extends a contract Evolent has held since fiscal 2018 to provide administrative simplification services to support CountyCare's 425,000 Medicaid…

Evolent Health (NYSE:EVH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:02 PM. Here's what investors need to know about the announcement.

Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts estimate that Evolent Health will report an earnings per share (EPS) of $0.01.